SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 5

Successful treatment of pediatric post-liver transplant Kaposi’s sarcoma with paclitaxel

Hilal SUSAM ŞEN
Belen ATEŞ
Pınar YILMAZBAŞ
Süheyla OCAK
Hale KIRIMLIOĞLU
Selim GÖKÇE
Koray ACARLI
Pages
858–862
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Paclitaxel should be considered as an effective first line treatment option for patients with post-transplant KS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kaposi’s sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients.
📊
Key Findings & Data:Unlike adult recipients, KS in pediatric organ transplantation is quite rare.
💡
Conclusion & Impact:Paclitaxel should be considered as an effective first line treatment option for patients with post-transplant KS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background. Kaposi’s sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients. Unlike adult recipients, KS in pediatric organ transplantation is quite rare. Treatment is usually withdrawal of immunosuppression; non-responders often receive chemotherapy. Case. We have reported a child with post-liver transplant visceral KS which has progressed despite withdrawal of immunosuppressive therapy, who has been treated with Paclitaxel for three weeks. KS has regressed completely after four cycles of Paclitaxel.Conclusion. Paclitaxel should be considered as an effective first line treatment option for patients with post-transplant KS.

🔖

Cite This Article

ŞEN, H. S., ATEŞ, B., YILMAZBAŞ, P., OCAK, S., KIRIMLIOĞLU, H., GÖKÇE, S., ACARLI, K. (2020). Successful treatment of pediatric post-liver transplant Kaposi’s sarcoma with paclitaxel. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 5, 858–862. https://ajindex.com/articles/411814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi sarcoma. Am J Clin Dermatol 2017
  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011
  3. Stewart S, Jablonowski H, Goebel FD, et al. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi’s sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol 1998
  4. Gill PS, Tulpule A, Espina BM, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi’s sarcoma. J Clin Oncol 1999
  5. Patel N, Salifu M, Sumrani N, et al. Successful treatment of post-renal transplant Kaposi’s sarcoma with paclitaxel. Am J Transplant 2002
  6. Debray D, Baudouin V, Lacaille F, et al
  7. Pediatric Transplantation Working Group of the French Speaking Society of Transplantation. De novo malignancy after solid organ transplantation in children. Transplant Proc 2009
  8. 674–675. 7.Yuksekkaya HA, Arikan C, Yazici A, Baran M, Aydogdu S, Kilic M. Successful treatment of a child having generalized Kaposi’s sarcoma after living donor liver transplantation with conversion to sirolimus. Pediatr Transplant 2009
  9. Celtik C, Unüvar A, Aydoğan A, et al. Human herpes virus type 8-associated Kaposi sarcoma in a pediatric liver transplant recipient. Pediatr Transplant 2011
  10. E100-E104. 9.Guba M, Yezhelyev M, Eichhorn ME, et al. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood 2005
  11. Aseni P, Vertemati M, Minola E, et al. Kaposi’s sarcoma in liver transplant recipients: morphological and clinical description. Liver Transpl 2001
  12. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995
  13. Francès C. Kaposi’s sarcoma after renal transplantation. Nephrol Dial Transplant 1998
  14. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 2005
  15. Tschachler E. Kaposi sarcoma. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D, (eds). Fitzpatrick’s Dermatology in General Medicine (7th ed). New York: McGrow-Hill, 2008: 1183-1187. 15.Vacca A, Ribatti D, Iurlaro M, et al. Docetaxel versus paclitaxelfor antiangiogenesis. J Hematother Stem Cell Res 2002
  16. Saville MW, L